Q&A: TGen's Glen Weiss on microRNAs as Lung Cancer Biomarkers
June 17, 2010
Q&A: TGen's Glen Weiss on microRNAs as Lung Cancer Biomarkers
According to a paper published in the Journal of Thoracic Oncology, miR-92a-2* may have potential as a patient-screening biomarker for small cell lung cancer patients resistant to chemotherapy.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Q&A: TGen's Glen Weiss on Identifying microRNA Biomarkers for Chemotherapy Resistance
January 21, 2010 / Gene Silencing News - UniQure, Collaborators Secure $3.2M Eurostar Grant for Huntington’s Disease Effort
May 23, 2013 / Gene Silencing News - NIH Awards $400K to Fund Three microRNA Research Grants in May
May 23, 2013 / Gene Silencing News - MiRagen Hits First Milestone in Servier microRNA Drug Partnership
May 23, 2013 / Gene Silencing News - Cenix to Provide Research Services to Debiopharm
May 23, 2013 / Gene Silencing News